MAQAF Stock Chart & Stats
$3.54
-$0.66(-16.67%)
At close: 4:00 PM EDT
$3.54
-$0.66(-16.67%)
Day’s Range― - ―
52-Week Range$2.58 - $4.09
Previous CloseN/A
Volume500.00
Average Volume (3M)16.00
Market Cap
$5.02B
Enterprise Value$8.55K
Total Cash (Recent Filing)$274.40M
Total Debt (Recent Filing)$1.75B
Price to Earnings (P/E)32.8
Beta0.28
Next Earnings
Aug 27, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend Yield7.37%
Share Statistics
EPS (TTM)0.15
Shares Outstanding1,453,493,400
10 Day Avg. Volume20
30 Day Avg. Volume16
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)1.22
Price to Sales (P/S)44.25
P/FCF Ratio11.54
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$3.50Price Target Upside-1.09% Downside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)0.2
Revenue Forecast (FY)$139.52M
Bulls Say, Bears Say
Bulls Say
Revenue And EBITDA GrowthGrowth across toll revenue and EBITDA indicates continued pricing, traffic and portfolio support. If sustained, this improves the company’s ability to fund maintenance, service debt and preserve distributions over the medium term.
Resilient Operating MarginsA stable 75% EBITDA margin demonstrates the operating leverage and cash-generative nature of mature toll-road concessions. Margin resilience provides protection against moderate cost inflation and supports more predictable long-term infrastructure cash flows.
Improving Cash Generation And LiquidityStronger operating and free cash flow improves funding capacity for debt service, lifecycle investment and distributions. Combined with available corporate liquidity, this gives Atlas Arteria greater flexibility to manage concession obligations and pursue measured growth.
Bears Say
French Temporary Supplemental Tax PressureThe extended French tax directly reduces cash received from key businesses and weakens near-term free cash flow coverage. Continued fiscal intervention could constrain distributions or reduce funds available for reinvestment across the portfolio.
French Concession Regulatory UncertaintyPotentially shorter concessions, smaller perimeters and tighter regulation could reduce the duration or economics of Atlas Arteria’s French assets. This creates lasting uncertainty around renewal terms, future investment returns and portfolio cash-flow durability.
Inconsistent Underlying ProfitabilityWeak and volatile operating profitability suggests reported earnings may depend on non-operating items or changing cost conditions. This reduces confidence in the sustainability of earnings and makes long-term cash-flow forecasting more difficult.
Atlas Arteria News
MAQAF FAQ
What was Atlas Arteria’s price range in the past 12 months?
Atlas Arteria lowest stock price was $2.58 and its highest was $4.09 in the past 12 months.
What is Atlas Arteria’s market cap?
Atlas Arteria’s market cap is $5.02B.
When is Atlas Arteria’s upcoming earnings report date?
Atlas Arteria’s upcoming earnings report date is Aug 27, 2026 which is in 6 days.
How were Atlas Arteria’s earnings last quarter?
Atlas Arteria released its earnings results on Feb 25, 2026. The company reported $0.211 earnings per share for the quarter, missing the consensus estimate of $0.214 by -$0.003.
Is Atlas Arteria overvalued?
According to Wall Street analysts Atlas Arteria’s price is currently Overvalued.
Does Atlas Arteria pay dividends?
Atlas Arteria pays a Semiannually dividend of $0.138 which represents an annual dividend yield of 7.37%. See more information on Atlas Arteria dividends here
What is Atlas Arteria’s EPS estimate?
Atlas Arteria’s EPS estimate is 0.12.
How many shares outstanding does Atlas Arteria have?
Atlas Arteria has 1,453,493,400 shares outstanding.
What happened to Atlas Arteria’s price movement after its last earnings report?
Atlas Arteria reported an EPS of $0.211 in its last earnings report, missing expectations of $0.214. Following the earnings report the stock price went up 1.062%.
Which hedge fund is a major shareholder of Atlas Arteria?
Currently, no hedge funds are holding shares in MAQAF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Atlas Arteria Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.50 (-1.09% Downside)
$3.50 (-1.09% Downside)
Blogger Sentiment
Neutral
MAQAF Sentiment 50%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.72%
12-Months-Change
Fundamentals
Return on Equity
7.37%
Trailing 12-Months
Asset Growth
-0.17%
Trailing 12-Months
Company Description
Atlas Arteria
Atlas Arteria Limited specializes in the acquisition, development, and management of toll road assets. Among its key holdings is a 13.4% equity stake in Toll Road Investors Partnership II (TRIP II), the concessionaire responsible for the 22-kilometer Dulles Greenway toll road, situated in Virginia, United States. The company was established in 2009 and operates from its corporate headquarters in Melbourne, Australia. It formally rebranded from Macquarie Atlas Roads Limited to its current name, Atlas Arteria Limited, in May 2018.
MAQAF Stock 12 Month Forecast
Average Price Target
$3.50
▼(-1.09% Downside)
Technical Analysis
Qube Holdings
―
Brambles
―
Aurizon Holdings
―
Transurban Group
―
Dalrymple Bay Infrastructure Ltd.
―
Ownership Overview
0.08% Insiders
8.44% Mutual Funds
<0.01% Other Institutional Investors
85.52% Public Companies and
Individual Investors